# Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19

> **NCT04632706** · PHASE1 · COMPLETED · sponsor: **MedinCell S.A** · enrollment: 24 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04632706
- **Lead sponsor:** MedinCell S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2021-03-09
- **Final completion:** 2021-03-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632706, "Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04632706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*